Trial Profile
Efficacy and safety of sacubitril/valsartan (LCZ696) in Chinese patients with Ischemic cardiomyopathy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Benazepril
- Indications Heart failure
- Focus Therapeutic Use
- 24 Oct 2018 New trial record